Immunohistochemical validation of INI1/SMARCB1 in a spectrum of musculoskeletal tumors: An experience at a tertiary cancer referral centre

Pathology Research and Practice

Volumn 209, Issue 12, 2013, Pages 758-766

  Rekhi, Bharat ^a   A Jambhekar, Nirmala ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Epithelioid sarcoma; Extrarenal rhabdoid tumor; Immunohistochemistry of sarcomas; INI1 SMARCB1 hSNF5 BAF47; Synovial sarcoma

Indexed keywords

NUCLEAR PROTEIN; PROTEIN INI1; PROTEIN SMARCB1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE BIOPSY; CANCER LOCALIZATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EPITHELIOID SARCOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MUSCULOSKELETAL DISEASE; MUSCULOSKELETAL TUMOR; MYOEPITHELIOMA; PROTEIN EXPRESSION; RHABDOID TUMOR; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SOFT TISSUE TUMOR; SYNOVIAL SARCOMA; VALIDATION PROCESS;

EPITHELIOID SARCOMA; EXTRARENAL RHABDOID TUMOR; IMMUNOHISTOCHEMISTRY OF SARCOMAS; INI1/SMARCB1/HSNF5/BAF47; SYNOVIAL SARCOMA;

ADOLESCENT; ADULT; AGED; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; CHROMOSOMAL PROTEINS, NON-HISTONE; DIAGNOSIS, DIFFERENTIAL; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MIDDLE AGED; MUSCLE NEOPLASMS; RHABDOID TUMOR; SARCOMA; SARCOMA, SYNOVIAL; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84887826471     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2013.08.008     Document Type: Article

References (40)

1. Roberts C.W., Orkin S.H. The SWI/SNF complex-chromatin and cancer. Nat. Rev. Cancer. 2004, 4:133-142.
2. Versteege I., Sévenet N., Lange J., Rousseau-Merck M.F., Ambros P., Handgretinger R., Aurias A., Delattre O. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 1998, 394:203-206.
3. Rousseau-Merck M.F., Versteege I., Legrand I., Couturier J., Mairal A., Delattre O., Aurias A. hSNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors. Cancer Res. 1999, 59:3152-3156.
4. Hoot A.C., Russo P., Judkins A.R. Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors. Am. J. Surg. Pathol. 2004, 28:1485-1491.
5. Judkins A.R., Mauger J., Ht A., Rorke L.B., Biegel J.A. Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms. Am. J. Surg. Pathol. 2004, 28:644-650.
6. Haberler C., Laggner U., Slavc I., Czech T., Ambros I.M., Ambros P.F., Budka H., Hainfellner J.A. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype. Am. J. Surg. Pathol. 2006, 30:1462-1468.
7. Sigauke E., Rakheja D., Maddox D.L., Hladik C.L., White C.L., Timmons C.F., Raisanen J. Absence of expression of SMARCB1/INI1 in malignant rhabdoid tumors of the central nervous system, kidneys and soft tissue: an immunohistochemical study with implications for diagnosis. Mod. Pathol. 2006, 19:717-725.
8. Modena P., Lualdi E., Facchinetti F., Galli L., Teixeira M.R., Pilotti S., Sozzi G. SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas. Cancer. Res. 2005, 65:4012-4019.
9. Hornick J.L., Dal Cin P., Fletcher C.D. Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma. Am. J. Surg. Pathol. 2009, 33:542-550.
10. Graham R.P., Dry S., Li X., Binder S., Bahrami A., Raimondi S.C., Dogan A., Chakraborty S., Souchek J.J., Folpe A.L. Ossifying fibromyxoid tumor of soft parts: a clinicopathologic, proteomic, and genomic study. Am. J. Surg. Pathol. 2011, 35:1615-1625.
11. Mobley B.C., McKenney J.K., Bangs C.D., Callahan K., Yeom K.W., Schneppenheim R., Hayden M.G., Cherry A.M., Gokden M., Edwards M.S., Fisher P.G., Vogel H. Loss of SMARCB1/INI1 expression in poorly differentiated chordomas. Acta Neuropathol. 2010, 120:745-753.
12. Kohashi K., Oda Y., Yamamoto H., Tamiya S., Matono H., Iwamoto Y., Taguchi T., Tsuneyoshi M. SMARCB1/INI1 protein expression in round cell soft tissue sarcomas associated with chromosomal translocations involving EWS: a special reference to SMARCB1/INI1 negative variant extraskeletal myxoid chondrosarcoma. Am. J. Surg. Pathol. 2008, 32:1168-1174.
13. Kohashi K., Izumi T., Oda Y., Yamamoto H., Tamiya S., Taguchi T., Iwamoto Y., Hasegawa T., Tsuneyoshi M. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor. Hum. Pathol. 2009, 40:349-355.
14. Kohashi K., Oda Y., Yamamoto H., Tamiya S., Matono H., Iwamoto Y., Taguchi T., Tsuneyoshi M. Reduced expression of SMARCB1/INI1 protein in synovial sarcoma. Mod. Pathol. 2010, 23:981-990.
15. Hulsebos T.J., Plomp A.S., Wolterman R.A., Robanus-Maandag E.C., Baas F., Wesseling P. Germline mutation of INI1/SMARCB1 in familial schwannomatosis. Am. J. Hum. Genet. 2007, 80:805-810.
16. Rousseau G., Noguchi T., Bourdon V., Sobol H., Olschwang S. SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosis. BMC Neurol. 2011, 11:9.
17. Patil S., Perry A., Maccollin M., Dong S., Betensky R.A., Yeh T.H., Gutmann D.H., Stemmer-Rachamimov A.O. Immunohistochemical analysis supports a role for INI1/SMARCB1 in hereditary forms of schwannomas, but not in solitary, sporadic schwannomas. Brain Pathol. 2008, 18:517-519.
18. Oda Y., Dal Cin P., Laskin W.B. Epithelioid sarcoma. World Health Organization (WHO) classification of tumors of soft tissue and bone 2013, 216-218. IARC Press, Lyon. 4th ed. C.D. Fletcher, J.A. Bridge, P.C.W. Hogendoorn, F. Mertens (Eds.).
19. Oda Y., Biegel J.A. Extrarenal rhabdoid tumor. World Health Organization (WHO) classification of tumors of soft tissue and bone 2013, 228-229. IARC Press, Lyon. 4th ed. C.D. Fletcher, J.A. Bridge, P.C.W. Hogendoorn, F. Mertens (Eds.).
20. Rekhi B., Gorad B.D., Chinoy R.F. Clinicopathological features with outcomes of a series of conventional and proximal-type epithelioid sarcomas, diagnosed over a period of 10 years at a tertiary cancer hospital in India. Virchows Arch. 2008, 453:141-153.
21. Chase D.R., Enzinger F.M. Epithelioid sarcoma. Diagnosis, prognostic indicators, and treatment. Am. J. Surg. Pathol. 1985, 9:241-263.
22. Evans H.L., Baer S.C. Epithelioid sarcoma: a clinicopathologic and prognostic study of 26 cases. Semin. Diagn. Pathol. 1993, 10:286-291.
23. Spillane A.J., Thomas J.M., Fisher C. Epithelioid sarcoma: the clinicopathological complexities of this rare soft tissue sarcoma. Ann. Surg. Oncol. 2000, 7:218-225.
24. Miettinen M., Fanburg-Smith J.C., Virolainen M. Epithelioid sarcoma: an immunohistochemical analysis of 11 classical and variant cases and a discussion of the differential diagnosis. Hum. Pathol. 1999, 30:934-942.
25. Hasegawa T., Matsuno Y., Shimoda T., Umeda T., Yokoyama R., Hirohashi S. Proximal-type epithelioid sarcoma: a clinicopathologic study of 20 cases. Mod. Pathol. 2001, 14:655-663.
26. Sevenet N., Sheridan E., Amram D., Schneider P., Handgretinger R., Delattre O. Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. Am. J. Hum. Genet. 1999, 65:1342-1348.
27. von Hochstetter A.R., Cserhati M.D. Epithelioid sarcoma presenting as chronic synovitis and mistaken for osteosarcoma. Skeletal Radiol. 1995, 24:636-638.
28. Hurtado R.M., McCarthy E., Frassica F., Holt P.A. Intraarticular epithelioid sarcoma. Skeletal Radiol. 1998, 27:453-456.
29. Kosemehmetoglu K., Kaygusuz G., Bahrami A., Raimondi S.C., Kilicarslan K., Yildiz Y., Folpe A.L. Intra-articular epithelioid sarcoma showing mixed classic and proximal-type features: report of 2 cases, with immunohistochemical and molecular cytogenetic INI-1 study. Am. J. Surg. Pathol. 2011, 35:891-897.
30. Tirabosco R., Flanagan A.M. INI1 expression in cytokeratin positive tumors of bone. Mod. Pathol. 2010, 23(Suppl. 1). 119.29A (abstr).
31. Kreiger P.A., Judkins A.R., Russo P.A., Biegel J.A., Lestini B.J., Assanasen C., Pawel B.R. Loss of INI1 expression defines a unique subset of pediatric undifferentiated soft tissue sarcomas. Mod. Pathol. 2009, 22:142-150.
32. Judkins A.R. Immunohistochemistry of INI1 expression: a new tool for old challenges in CNS and soft tissue pathology. Adv. Anat. Pathol. 2007, 14:335-339.
33. Hollmann T.J., Hornick J.L. INI1-deficient tumors: diagnostic features and molecular genetics. Am. J. Surg. Pathol. 2011, 35:e47-e63.
34. Trobaugh-Lotrario A.D., Tomlinson G.E., Finegold M.J., Gore L., Feusner J.H. Small cell undifferentiated variant of hepatoblastoma: adverse clinical and molecular features similar to rhabdoid tumors. Pediatr. Blood Cancer 2009, 52:328-334.
35. Mobley B.C., McKenney J.K., Bangs C.D. Loss of SMARCB1/INI1 expression in poorly differentiated chordomas. Acta Neuropathol. 2010, 120:745-753.
36. Rekhi B., Sable M., Jambhekar N.A. Histopathological, immunohistochemical and molecular spectrum of myoepithelial tumours of soft tissues. Virchows Arch. 2012, 461:687-697.
37. Donner L.R., Wainwright L.M., Zhang F., Biegel J.A. Mutation of the INI1 gene in composite rhabdoid tumor of the endometrium. Hum. Pathol. 2007, 38:935-939.
38. Cho Y.M., Choi J., Lee O.J., Lee H.I., Han D.J., Ro J.Y. SMARCB1/INI1 missense mutation in mucinous carcinoma with rhabdoid features. Pathol. Int. 2006, 56:702-706.
39. Mularz K., Harazin-Lechowska A., Ambicka A., Kruczak A., Rozmus-Pietoń M., Marchińska-Osika U., Swiatkiewicz I., Król M., Pabis D., Januś G., Ryś J. Specificity and sensitivity of INI-1 labelling in epithelioid sarcoma. Loss of INI1 expression as a frequent immunohistochemical event in synovial sarcoma. Pol. J. Pathol. 2012, 63:179-183.
40. Arnold M.A., Arnold C.A., Li G., Chae U., El-Etriby R., Lee C.C., Tsokos M. A unique pattern of INI1 immunohistochemistry distinguishes synovial sarcoma from its histologic mimics. A unique pattern of INI1 immunohistochemistry distinguishes synovial sarcoma from its histologic mimics. Hum. Pathol. 2013, 44:881-887.